Chronic administration of Empagliflozin induces cardioprotection in vivo in absence of diabetes mellitus

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Mechanisms underlying pharmacotherapy Antidiabetic Pharmacotherapy ESC Premium Access ESC Congress 2019